"Much-Needed Win": Novo Shares Jump Most In Nearly Two Years After US Approval Of Wegovy Obesity Pill
#Zap to support, DM to suggest new feeds.
"Much-Needed Win": Novo Shares Jump Most In Nearly Two Years After US Approval Of Wegovy Obesity Pill | ZeroHedge
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero